| Application no. and date | 20705746.4 (espacenet) (Federated) (European Patent Register), 20200225 | | Patent/reg. no. and date | DK/EP 3930703, 20231227 | | Publication date | 20220105 | | Priority no. and date | IT 201900003013, 20190301 | | EP pub. no. and date |
EP 3930703 20220105 | | Effective date | | | Applicant/owner | IBSA INSTITUT BIOCHIMIQUE SA, Via Pian Scairolo 49
CH - 6912 Lugano
, CH | | Applicant ref. no. | P24-003WEDK | | Inventor | FOSSATI, Tiziano, c/o ALTERGON S.A. Via Dogana Vecchia, 2
6900 Lugano, CH,
MAUTONE, Giuseppe, c/o ALTERGON S.A. Via Dogana Vecchia, 2
6900 Lugano, CH,
SCARSI, Claudia, c/o ALTERGON S.A. Via Dogana Vecchia, 2
6900 Lugano, CH | | Representative | Patentgruppen A/S, Arosgården, Åboulevarden 31, 8000 Aarhus C | | Opponent | | | IPC Class | A61K 31/198 (2006.01) , A61K 47/10 (2017.01) , A61K 9/08 (2006.01) , A61P 5/14 (2006.01) | | Title | ADMINISTRATION REGIMEN OF SOLUTIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION | | Int. application no. | EP2020054873 | | Int. publication no. | WO2020178074 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
